Progression from ocular hypertension to visual field loss in the English hospital eye service

被引:15
|
作者
Kelly, Stephen R. [1 ]
Khawaja, Anthony P. [2 ,3 ]
Bryan, Susan R. [1 ]
Azuara-Blanco, Augusto [4 ]
Sparrow, John M. [5 ,6 ]
Crabb, David P. [1 ]
机构
[1] City Univ London, Sch Hlth Sci, Div Optometry & Visual Sci, London, England
[2] Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London, England
[3] UCL, London, England
[4] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
[5] Univ Bristol, Bristol Eye Hosp, Populat Hlth Sci, Bristol, Avon, England
[6] Royal Coll Ophthalmologists, Royal Coll Ophthalmologists Natl Ophthalmol Datab, London, England
关键词
NATIONAL OPHTHALMOLOGY DATABASE; BASE-LINE FACTORS; SURGERY REPORT 1; SHARED CARE; GLAUCOMA; CONVERSION; ONSET; RISK;
D O I
10.1136/bjophthalmol-2019-315052
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background There are more than one million National Health Service visits in England and Wales each year for patients with glaucoma or ocular hypertension (OHT). With the ageing population and an increase in optometric testing, the economic burden of glaucoma-related visits is predicted to increase. We examined the conversion rates of OHT to primary open-angle glaucoma (POAG) in England and assessed factors associated with risk of conversion. Methods Electronic medical records of 45 309 patients from five regionally different glaucoma clinics in England were retrospectively examined. Conversion to POAG from OHT was defined by deterioration in visual field (two consecutive tests classified as stage 1 or worse as per the glaucoma staging system 2). Cox proportional hazards models were used to examine factors (age, sex, treatment status and baseline intraocular pressure (IOP)) associated with conversion. Results The cumulative risk of conversion to POAG was 17.5% (95% CI 15.4% to 19.6%) at 5 years. Older age (HR 1.35 per decade, 95% CI 1.22 to 1.50, p<0.001) was associated with a higher risk of conversion. IOP-lowering therapy (HR 0.45, 95% CI 0.35 to 0.57, p<0.001) was associated with a lower risk of conversion. Predicted 5-year conversion rates for treated and untreated groups were 14.0% and 26.9%, respectively. Conclusion Less than one-fifth of OHT patients managed in glaucoma clinics in the UK converted to POAG over a 5-year period, suggesting many patients may require less intensive follow-up. Our study provides real-world evidence for the efficacy of current management (including IOP-lowering treatment) at reducing risk of conversion.
引用
收藏
页码:1406 / 1411
页数:6
相关论文
共 50 条
  • [1] Visual Field Progression in the Ocular Hypertension Treatment Study
    Gordon, Mae o.
    Heuer, Dale k.
    Higginbotham, Eve j.
    Parrish, Richard k.
    Liu, Lei
    Brandt, James d.
    Huecker, Julia b.
    Miller, J. phillip
    Perera, Chamila
    Xie, Chris
    Keltner, John l.
    Johnson, Chris a.
    Gardiner, Stuart k.
    Liebmann, Jeffrey m.
    Kass, Michael a.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 271 : 360 - 370
  • [2] Prediction model of visual field progression in the Ocular Hypertension Treatment Study
    Gordon, Mae O.
    Heuer, Dale K.
    Higginbotham, Eve J.
    Parrish, Richard K.
    Johnson, Chris A.
    Liu, Lei
    Kass, Michael A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [3] Machine-Identified Patterns of Visual Field Loss and an Association with Rapid Progression in the Ocular Hypertension Treatment Study
    Yousefi, Siamak
    Pasquale, Louis R.
    Boland, Michael, V
    Johnson, Chris A.
    OPHTHALMOLOGY, 2022, 129 (12) : 1402 - 1411
  • [4] Late progression of visual loss from ocular quinine toxicity
    Jiao, Yuanzhang
    O'Day, Roderick F. J.
    O'Day, Justin
    Mack, Heather G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (04): : E116 - E119
  • [5] Visual field loss and corneal parameters in open angle glaucoma and ocular hypertension
    Gunvant, P
    Baskaran, M
    Vijaya, L
    Watkins, RJ
    Broadway, DC
    O'Leary, DJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U371 - U371
  • [6] RISK-FACTORS FOR THE DEVELOPMENT OF GLAUCOMATOUS VISUAL-FIELD LOSS IN OCULAR HYPERTENSION
    QUIGLEY, HA
    ENGER, C
    KATZ, J
    SOMMER, A
    SCOTT, R
    GILBERT, D
    ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (05) : 644 - 649
  • [7] Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc
    Leshno, Ari
    Bommakanti, Nikhil
    De Moraes, Carlos Gustavo
    Gordon, Mae O.
    Kass, Michael A.
    Cioffi, George A.
    Liebmann, Jeffrey M.
    EYE, 2024, 38 (08) : 1549 - 1555
  • [8] Rate of Visual Field Progression in Eyes With Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study
    De Moraes, Carlos Gustavo
    Demirel, Shaban
    Gardiner, Stuart K.
    Liebmann, Jeffrey M.
    Cioffi, George A.
    Ritch, Robert
    Gordon, Mae O.
    Kass, Michael A.
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (12) : 1541 - 1546
  • [9] RISK-FACTORS FAVORING THE DEVELOPMENT OF GLAUCOMATOUS VISUAL-FIELD LOSS IN OCULAR HYPERTENSION
    KASS, MA
    HART, WM
    GORDON, M
    MILLER, JP
    SURVEY OF OPHTHALMOLOGY, 1980, 25 (03) : 155 - 162
  • [10] Longitudinal and Cross-sectional Analyses of Visual Field Progression in Participants of the Ocular Hypertension Treatment Study
    Artes, Paul H.
    Chauhan, Balwantray C.
    Keltner, John L.
    Cello, Kim E.
    Johnson, Chris A.
    Anderson, Douglas R.
    Gordon, Mae O.
    Kass, Michael A.
    ARCHIVES OF OPHTHALMOLOGY, 2010, 128 (12) : 1528 - 1532